Symposium:
007. What's Hot in ID + HIV
Wednesday, October 4, 2017: 1:30 PM-3:30 PM
Room: 20ABCD

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe what is new in the fields of infectious diseases basic and clinical science
  • describe what is new in the fields of basic science and pathogenesis of HIV
  • describe what is new in HIV clinical care and epidemiology

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, HIV clinicians, HIV specialists, Hospital administrators, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists, Vaccinologists

Tracks: Trainee, Pediatric ID, Investigative ID, HIV-STD-TB, Global ID, Epidemiology and Infection Control, Adult ID


Moderators:  David R. Andes, M.D., FIDSA, University of Wisconsin School of Medicine and Public Health and Eric Daar, MD, Harbor-UCLA Medical Center

Presentations:
1:30 PM
20
What's Hot in ID Clinical Science
Stan Deresinski, MD, FIDSA

2:00 PM
21
What's Hot in ID Basic Science
Liise-Anne Pirofski, MD, FIDSA

2:30 PM
22
What’s Hot in HIV Clinical Science
Wendy Armstrong, MD, FIDSA

3:00 PM
23
What’s Hot in HIV Basic Science
Joel Blankson, MD, PhD

CME Credits: Maximum of 2.00 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 2 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-224-L02-P

Disclosures:

D. R. Andes, Medicines: Consultant , Consulting fee
Zavante: Consultant and Grant Investigator , Consulting fee and Grant recipient
Paratek: Research Contractor , Research grant
Actelion: Grant Investigator , Grant recipient
Amplyx: Grant Investigator , Grant recipient
Geom: Grant Investigator , Grant recipient
Meiji: Grant Investigator , Grant recipient
Cidaria: Grant Investigator , Grant recipient
Theravance: Consultant and Grant Investigator , Consulting fee and Grant recipient
Astellas: Grant Investigator , Grant recipient

E. Daar, Bristol Myers Squibb: Consultant , Consulting fee
Gilead: Consultant and Grant Investigator , Consulting fee and Research grant
Janssen: Consultant , Consulting fee
Merck: Consultant and Grant Investigator , Consulting fee and Research grant
Teva: Consultant , Consulting fee
Theratechnologies: Consultant , Consulting fee
ViiV: Consultant and Grant Investigator , Consulting fee and Grant recipient

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.